Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123143) titled 'becotatug vedotin combined with Pucotenlimab for the treatment of locally advanced nasopharyngeal carcinoma' on April 22.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Zhejiang Cancer Hospital

Condition: Nasopharyngeal carcinoma

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-05-01

Target Sample Size: experimental group:58;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=313985

Published by HT Digital Content Services with permission from Health Daily Digest....